stuff Arsh probably should memorize but won't Flashcards

(93 cards)

1
Q

Provide drugs that can be used for urinary incontinence.

A
  • Treatment
    • Medications – oxybutynin (muscarinic (M3) antagonist → treats OAB), tolteridine (muscarinic (M3) antagonist → treats OAB), flavoxate (anticholinergic → relax smooth muscles), imipramine (beta agonist → treats OAB)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the two treatments for bacterial vaginosis?

  • For each, provide MOA, SOA, SE
A
  • Tx (both cause NVD)
    • Metronidazole (po, topical)
      • MOA: inhibits nucleic acid synthesis → disrupts bacterial DNA → bacteriostatic
      • SOA: anaerobes, protozoa, and microaerophilic bacteria
      • SE: disulfiram reaction (no alcohol), metallic taste, CYP2C9 inhibitor (increases warfarin levels)
    • Clindamycin (topical)
      • MOA: binds 50s rRNA → inhibits translocation → bactericidal
      • SOA: gram positive bacteria and anaerobes
      • SE: pseudomembranous colitis (C. Diff)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

SERMS

  • MOA?
  • 2 examples?
  • SE?
A
  • SERMs – competitive inhibitors of estrogen binding to estrogen receptors on tumor tissue
    • i.e. Tamoxifen, Raloxifene
    • SE: hot flashes, endometrial hyperplasia/cancer, DVT, cataracts (due to agonist effects)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Aromatase inhibitor

  • MOA?
  • SE?
A
  • Aromatase inhibitors – blocks conversion of androgens to estrogen
    • SE: decreased bone density, joint pains, vaginal atrophy, hyperlipidemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Trastuzamab

  • MOA?
  • SE?
A
  • Trastuzumab (Herceptin) – MAB that binds to the extracellular domain of HER2 → inhibiting HER1 and HER2 dimerization → blocking cellular proliferation and angiogenesis
    • SE: LV dysfunction → CHF, hypersensitivity, pulmonary toxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the functions of the following Placental peptide hormones

Leptin, neuropeptide Y, inhibin & activan

A
  • Leptin: anti-obesity hormone normally secreted by adipocytes → decreased food intake
  • Neuropeptide Y: secreted from cytotrophoblasts → increase in CRH release
  • Inhibin and Activin:
    • Inhibin: secreted by ovarian granulosa cells → ceases possibility of ovulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

define the following

threatened, inevitable, incomplete, complete, missed abortion

how to treat missed abortion

A
  • Threatened abortion (miscarriage): bleeding in first trimester without loss of fluid or tissue
  • Inevitable abortion (miscarriage): bleeding or rupture of membranes in the presence of cervical dilatation (>2 cm – can put speculum in cervix)
  • Incomplete abortion (miscarriage): documented pregnancy where passage of some blood and some tissue occurs, but some products of conception remain within the uterus
  • Complete abortion (miscarriage): documented pregnancy that ends with the spontaneous passage of all of the products of conception
  • Missed abortion (miscarriage): the retention of a failed intrauterine pregnancy with a gestational age less than 28 weeks, for 8 weeks or more
    • Expectant Tx, Dilation and curettage, and misoprostol (painful)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the FDA drug classifications

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

FAS

patho? abnormalities?

A
  • Pathogenesis: failure of cell migration during gestation
  • Congenital abnormalities: growth restriction, facial abnormalities (shortened palpebral tissues, low-set ears, midfacial hypoplasia, smooth philtrum, and thin upper lip) and CNS dysfunction (microcephaly, mental retardation, and ADD)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Leading cause of low birth weight, pre-term labor, placental problems, IUGR, SIDS

A

Nicotine (vasoconstriction) and CO (impaired O2 delivery)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Associated with low birth weight, pre-term birth, IUGR, and placental abruption

A

Cocaine (vasoconstriction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Most common teratogen that causes birth defects, intellectual disability, fetal alcohol syndrome (FAS)***

A

Alcohol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  • Exposure to less than 5 rads is not associated with fetal anomalies

If exposed to more leads to microcephaly and intellectual disability

A

Radiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Associated with irreversible arthroapthies and cartilage erosion

A

Aminoglycosides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Associated with yellow-brown discoloration of teeth and inhibited bone growth

A

Tetracycline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Ototoxicity

A

Aminoglycosides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Avoid near delivery as they are associated with hyperbilirubinemia

A

Sulfa drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Often used in pregnancy, but is associated with hemolytic anemia in G6PD deficiency

A

Nitrofurantoin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Avoid near delivery as they are associated with thrombocytopenia, bleeding, and electrolyte disturbances

A

Thiazide diuretics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Associated with fetal growth restriction, neonatal hypoglycemia, possible transient hypotension

A

Beta blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Renal damage → polyhydramnios (growth restriction, limb contractures, abnormal skull/calvarium development)

A

ACEi/ARBs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Only SSRI with an increased risk of ventral/atrial septal cardiac defects

A

Paroxetine (SSRI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Avoid use late in pregnancy as it is associated with neonatal behavioral syndrome (increased muscle tone, irritability, jitteriness, & respiratory distress)

A

SSRIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Associated with Ebstein anomaly (apical displacement of the tricuspid valve → atrialization of the RV)

A

Lithium (depression med)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Associated with spina bifida/neural tube defects with exposure during embryogenesis → Tx: folate supplements before sex
Valproic acid and carbamazepine
27
Associated with abnormal facies, cleft lip/palate, microcephaly, growth deficiency, and hypoplasia of nails/DIPs
Phenytoin
28
Severe fetal malformation → contraception is mandatory with use
Isotretinoin (acne med) /VitA
29
* Methotrexate is used in ectopic pregnancy Contraindicated in normal pregnancy due to neural tube defects
Methotrexate/ Trimethoprim (folate antagonists)
30
* Easily crosses the placenta Contraindicated in first trimester as it is associated with bone deformities, fetal abnormalities, abortion, ophthalmologic abnormalities
Warfarin
31
Long-term use usually avoided as it can be associated with ductus arteriosus constriction → pulmonary HTN
NSAIDS
32
Associated with aplasia cutis congenita (absence of skin à hole in head)
Methimazole (hyperthyroidism med)
33
Associated with flipper limb defects
Thalidomide
34
Can result in caudal regression syndrome, congenital heart defects, macrosomia, and neonatal hypoglycemia
Diabetes
35
Associated with absence of digits and other anomalies
Alkylating agents (cancer drug)
36
Associated with vaginal clear cell carcinoma and congenital Müllerian anomalies
Diethylstilbestrol (DES)
37
Associated with congenital goiter or hypothyroidism (causes cretinism: stunted physical/mental growth)
Iodine (lack/excess)
38
explain the following drugs oxytocin, misoprostol, mehtylergonovine, prostaglandin F2/E2 MOA? SE? and contraindiactions
39
Found in swordfish, shark, tilefish, king mackerel → neurotoxicity Fish is safe when less than 12oz/week
Methylmercury
40
Provide the MOA of the two hormones involved in contraceptives?
* Progestin (prevents ovulation and fertilization) * Suppresses LH surge, thickens cervical mucus, reduces ovum motility, thins endometrium * Estrogen * Suppresses FSH, potentiates progestin
41
Provide the following generally: * half-life of each hormone * where are they metabolized * which two drugs do not have a rapid return to fertility? * what is the effect on obese patients? * What are general side effects of all?
* General pharmacokinetics/pharmacology * Half-life: estrogen (long), progestin (short * Metabolism: liver (P450s) * Return to fertility: rapid except for depo (9-10 months) and Nexplanon (1-2 months) * Effect in obese patients: Nexplanon and OCPs may be slightly less effective (others are equally effective) * General side effects: all can cause spotting of blood except copper IUD (can cause heavy bleeding)
42
For Surgical sterilization (vasectomy, tubal ligation, Essure): * MOA * Benefits * Risks
43
For Levonorgestrel (LNG) intrauterine device (IUD) (mirena, Skyla, kyleena): * MOA * Benefits * Risks
44
For Copper IUD (ParaGard): * MOA * Benefits * Risks
45
For Levonorgestrel implant (nexplanon): * MOA * Benefits * Risks
46
For Depot medroxyprogesterone acetate (aka Depo-provera): * MOA * Benefits * Risks
47
For Combined hormonal methods (oral contraceptive pill, ring, patch): * MOA * Benefits * Risks
48
For Progestin only pills (POP): * MOA * Benefits * Risks
49
For Barrier methods (condom, cervical cap, diaphragm): * MOA * Benefits * Risks
50
For Fertility awareness methods (calendar, temperature, cervical mucus): * MOA * Benefits * Risks
51
For Emergency contraception (Plan B/levonorgestrel): * MOA * Benefits * Risks
62
Two meds for medication induced abortion? Provide MOA and SE if any? When are these indicated?
* Medication-induced abortion (indicated up to 70 days with ~70% success) * Prostaglandin E1 analog – Misoprostol (given at very high dose on day 2) * MOA: cervical ripening and uterine contractions * SE: severe cramping, heavy bleeding * Antiprogesterone – Mifepristone (given day 1) * MOA: lack of progesterone à lack of uterine maintenance à abortion
63
* Phentermine (Adipex/Fastin)
* MOA: inhibits reuptake of monoamines (i.e. HT, DA, NE) → satiety * SE: tachycardia, palpitations, tremors, mood swings
64
* Orlistat (Xenical/Alli)
* MOA: lipase inhibitors → decreased fat absorption * SE: diarrhea, steatorrhea
65
* Lorcaserin (Belviq)
* MOA: selective serotonin agonist → stimulates POMC production → appetite suppression * SE: same as Phentermine (tachycardia, tremors, mood swings)
66
* Phentermine/Topiramate (Qysmia) – most effective
* MOA: diminishes appetite via unknown mechanism in hypothalamus * SE: fatigue, cognitive decline
67
* Buproprion/Naltrexone (Contrave)
* MOA: * Buproprion (anti-depressant): dopamine/norepinephrine reuptake inhibitor → stimulates POMC production → appetite suppression * Naltrexone: opioid antagonist → suppresses POMC inhibition → appetite suppression * SE: N/V, constipation
68
* Liraglutide (Saxenda) – same as Victoza (used to treat DM-2)
* MOA: injected GLP-1 (glucagon-like peptide) → increases insulin production and activates parts of brain involved in appetite suppression → weight loss * SE: C-cell hyperplasia (thyroid), nausea, abdominal pain, bloating
69
PCOS treatment talk about OCP, letrozole, clomiphene and metformin
* Overall treatment: metformin * Treats insulin resistance, some benefit to infertility/hirsutism * Letrozole (aromatase inhibitor) \> clomiphene (SERM) \> metformin * MOA (treats infertility): aromatase inhibitor → interferes with estrogen feedback at the hypothalamus → increased release of FSH from pituitary * Clomiphene * MOA (treats infertility): SERM → decreases estrogen feedback at the hypothalamus → increased release of FSH from pituitary * Risk: exacerbates metabolic dysfunction (increases BMI) * OCP: * Treats hirsutism and acne; prevents diabetes, CVD, and endometrial cancer * Risk: can worsen insulin resistance * Diet and exercise * Decreases incidence of diabetes
70
Glipizide
MOA:Blocks ATP-sensitive K-channels → membrane depolarization → influx of Ca → insulin release SE:Hyperinsulinemia, weight gain, hypoglycemia OTHER: Long acting
71
Repaglinide
MOA:Blocks ATP-sensitive K-channels → membrane depolarization → influx of Ca → insulin release SE:Hyperinsulinemia, weight gain, hypoglycemia OTHER: rapid acting
72
metformin
MOA: 1. Inhibits gluconeogenesis in liver (increased production of lactic acid instead of pyruvate) 2. Reduce insulin resistance via increased AMPK → increased GLUT4 expression SE:Diarrhea, decreased absorption of B9/B12, lactic acidosis OTHER: Contraindicated in renal dx due to lactic acidosis
73
Pioglitazone
MOA:Activates peroxisome proliferator-activator receptor gamma (PPAR-gamma) → activates insulin responsive genes → increase glucose uptake SE: Edema, fractures (due to decreased aromatase) OTHER:
74
acarbose
MOA:Inhibit alpha glucosidase → decreased breakdown of complex carbs → decreased glucose absorption in gut SE:Diarrhea (osmotic), abdominal pain OTHER:
75
Pramlintide
MOA:Synthetic analog of amylin (usually co-secreted with insulin) → enhances satiety, slows gastric emptying, suppresses glucagon (mirrors insulin effects) SE: N/V (slowed gastric emptying), hypoglycemia OTHER:
76
Exena**_tide_** Lirglu**_tide_**
MOA:GLP-1 receptor analog → increases insulin secretion → slows gastric emptying, suppresses glucagon (effects of GLP-1) SE:Nausea, bloating (delayed gastric emptying) OTHER: Take 60min BEFORE meal Risk of c-cell thyroid CA
77
Sitagliptin
MOA:Prevents degradation of GLP-1 → increases insulin secretion → slows gastric emptying, suppresses glucagon (effects of GLP-1) SE:Nausea, bloating (delayed gastric emptying) OTHER:
78
Canaglifozin
MOA: Reduces absorption of glucose from kidney → increase in urinary glucose, SGLT2i SE:UTI/yeast infection, dehydration, AKI, ketoacidosis OTHER:
79
difference between insulins * humulog/novolog * novolin * long acting
80
What are some treatments of thyrotoxicosis?
* Treatment: beta blockers, thionamides (methimazole, propylthiouracil), radioactive iodine (I-131 ablation), surgery (thyroidectomy)
81
Oxytocin MOA, SE, Use, other fun facts
**MOA:** Peptide binds Gq → release of Ca → contractions **SE:** Mom: Fluid retention (vasopressin is structurally similar to oxytocin) **USE:** Uterine contractions **OTHER:** Fetus: Uterine rupture, distress
82
Desmopressin MOA, SE, Use, other fun facts
**MOA:** ADH analog → fluid retention **SE:** Rhinitis, hyponatremia **USE:** Central diabetes insipidus (too little ADH) **OTHER:** Contraindicated: HF, uncontrolled HTN
83
Aquaretics: Coni**_vaptan_** MOA, SE, Use, other fun facts
**MOA:** ADH antagonist → water excretion **SE:** **USE:** Hyponatremia (too much ADH) **OTHER:** Used in patients with CHF
84
Dopamine receptor agonists: Bromocriptine MOA, SE, Use, other fun facts
**MOA:** Inhibits prolactin secretion and decreases GH release (unsure MOA) **SE:** Postural hypotension, N/V (CTZ), hallucinations **USE:** Hyperprolactinemia, acromegaly **OTHER:**
85
Dopamine receptor antagonists: Metoclopramide MOA, SE, Use, other fun facts
**MOA:** Inhibits dopamine → prolactin secretion occurs **SE:** **USE:** Hyperprolactinemia, acromegaly **OTHER:**
86
Pegvisomant (subQ) MOA, SE, Use, other fun facts
**MOA:** Growth hormone receptor antagonist **SE:** Infection (subQ), elevated LFTs **USE:** acromegaly **OTHER:**
87
Growth hormone replacement: Somatotropin, Somatrem MOA, SE, Use, other fun facts
**MOA:** Exogenous GH **SE:** Kids: elevated HbA1c, eosinophilia, increased risk of secondary malignancies Adults: fluid retention, myalgia **USE:** Dwarfism (GH deficiency) **OTHER:** Drug interactions: estrogens, androgens, thyroid hormones
88
GHRH injection: Sermorelin MOA, SE, Use, other fun facts
**MOA:** Exogenous GHRH → GH **SE:** Kids: elevated HbA1c, eosinophilia, increased risk of secondary malignancies Adults: fluid retention, myalgia **USE:** Dwarfism (GH deficiency) **OTHER:** Drug interactions: estrogens, androgens, thyroid hormones
89
Mecasemerin MOA, SE, Use, other fun facts
**MOA:** Exogenous IGF-1 → acts at insulin-like receptor → growth **SE:** Tonsillar hypertrophy, lipohypertrophy, hypoglycemia **USE:** IGF-1 deficiency in children (not GH deficient, but resistant to effects of GH) **OTHER:**
90
Fludrocortisone MOA, SE, Use, other fun facts
**MOA:** Aldo agonist → Na/H20 reabsorption **SE:** Fluid retention, hypokalemia **USE:** CAH: 11-beta hydroxylase deficiency, adrenal insufficiency **OTHER:**
91
Spironolact**_one_**, Epleren**_one_** MOA, SE, Use, other fun facts
**MOA:** Aldo antagonist → blocks Na/H20 reabsorption **SE:** Gynecomastia, menstrual issues (block androgen/ glucocorticoid receptors) **USE:** HTN, hypokalemia **OTHER:**
92
Aminoglutethemide MOA, SE, Use, other fun facts
**MOA:** Cholesterol desmolase inhibitor (rate-limiting step) **SE:** Extreme sedation, nausea, severe skin rashes **USE:** Cushing’s syndrome **OTHER:**
93
Metyrapone MOA, SE, Use, other fun facts
**MOA:** Inhibits 11-hydroxylase activity **SE:** Hirsutism (increased androgens), acne, HTN, N/V, sedation **USE:** Cushing’s syndrome **OTHER:**
94
Ketoconazole (antifungal) MOA, SE, Use, other fun facts
**MOA:** Inhibits 11-hydroxylase activity **SE:** Gynecomastia, low testosterone levels, elevates LFTs, CYP450 inhibitor **USE:** Cushing’s syndrome **OTHER:**
95
Mitotane MOA, SE, Use, other fun facts
**MOA:** Causes degeneration of zona fasiculata and reticularis cells → atrophy of adrenal gland **SE:** Lethargy and extreme sedation, CNS effects **USE:** Cushing’s syndrome **OTHER:** Use: Inoperable cortical carcinoma
96
Mifepristone MOA, SE, Use, other fun facts
**MOA:** Progesterone and glucocorticoid receptor antagonist **SE:** Vaginal bleeding, pregnancy termination, nausea **USE:** Cushing’s syndrome **OTHER:**
97
Hydrocortisone MOA, SE, Use, other fun facts
**MOA:** Activates cytosolic glucocorticoid receptors → release of cortisol **SE:** Cushingoid effects **USE:** Adrenal insufficiency, inflammation, asthma, eczema, etc **OTHER:** Metabolism slowed by estrogens, liver disease, age, pregnancy, hypothyroidism
98
Iodides MOA, SE, Use, other fun facts
**MOA:** Iodine analog → negative feedback of T3/T4 synthesis **SE:** Hypothyroidism SE **USE:** Short term hyperthyroidism (pre-operatively) **OTHER:**
99
Propylthiouracil (PTU) MOA, SE, Use, other fun facts
**MOA:** Substrate for TPO, inhibits MIT/DIT coupling to thyroglobulin, blocks peripheral conversion of T4/T3 **SE:** Hypothyroidism, rashes, arthralgias, SLE-like syndrome, hypersensitivity reactions, hepatotoxicity **USE:** Thyroid storm, hyperthyroidism, when methimazole is not tolerated **OTHER:** Indicated: pregnancy
100
Methimazole MOA, SE, Use, other fun facts
**MOA:** Substrate for TPO, inhibits MIT/DIT coupling to thyroglobulin, **SE:** Hypothyroidism, rashes, arthralgias, SLE-like syndrome, hypersensitivity reactions, birth defects **USE:** Hyperthyroidism **OTHER:**
101
Synthroid, Levothroid, Levothryxine MOA, SE, Use, other fun facts
**MOA:** Synthetic T4 (protein bound, can be converted to T3, slow onset) **SE:** Cardiac events **USE:** Hypothyroidism **OTHER:** Drug interactions: warfarin (TH reduces clotting factors), beta blockers Increased T4 clearance by: Rifampin, Phenytoin
102
Natural desiccated thyroid MOA, SE, Use, other fun facts
**MOA:** Animal T4 **SE:** Allergic reactions **USE:** Hypothyroidism **OTHER:** Drug interactions: warfarin (TH reduces clotting factors), beta blockers Increased T4 clearance by: Rifampin, Phenytoin
103
Liothyronine (Ctyomel) MOA, SE, Use, other fun facts
**MOA:** Synthetic T3 (fast onset, not protein bound) **SE:** Cardiac events **USE:** Hypothyroidism, myxedena **OTHER:** higher cost
104
Liotrix MOA, SE, Use, other fun facts
**MOA:** T4/T3 **SE:** Cardiac events **USE:** Hypothyroidism **OTHER:** EXPENSIVE